Page 41 | Certara

Press Coverage

Forbes: Adoption Of Model-Informed Drug Development Can Improve Pharma ROI

Published: November 27, 2024 Recent decades have seen continuing declines in pharmaceutical R&D productivity. Inflation…

CertaraNovember 27, 2024

Announcement

Major Release of Certara GlobalSubmit™ Software Enhances the Regulatory Submission Process

Radnor, PA – November 25, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in…

CertaraNovember 25, 2024

eBook

PK/PD Data Analysis, Concepts and Applications eBook

Accelerate your Journey: Learn & Grow with the Standard Book for PK Scientists

CertaraNovember 25, 2024

Fact Sheet

Automated Writing Without the Compromise

CertaraNovember 22, 2024

Poster

Population K-PD Modeling of Plozasiran (ARO-APOC3), a GalNAc-siRNA Conjugate, for the Treatment of Patients with Severe Hypertriglyceridemi

CertaraNovember 22, 2024

Poster

Population pharmacokinetic modeling of TBA-7371 in healthy participants describes apparent auto-induction of clearance and predicts PK in participants with Mycobacterium tuberculosis.

CertaraNovember 22, 2024

Poster

Impacts of dose titration on logistic exposure-response in simulated flexible-dose clinical trials

CertaraNovember 22, 2024

White Paper

Clinical Metadata Standardization: Evaluating the Importance of a Metadata Repository in Clinical Trials

Whether you’re considering a metadata repository or want to learn about clinical metadata standardization, our…

CertaraNovember 22, 2024

Poster

Simultaneous Population PKPD Analysis of Belantamab Mafodotin, Soluble BCMA, and Serum M-Protein in Subjects With Relapsed/Refractory Multiple Myeloma

CertaraNovember 22, 2024

Poster

A Pharmacokinetic Analysis of Drug Concentration Using a Novel Deep Learning Model

CertaraNovember 22, 2024

© 2025 Certara. All Rights Reserved. | Legal | Privacy policy